http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-691501-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25f5e60cca882cd756ee1cd36c3fef16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2408
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-26
filingDate 1951-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1953-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-691501-A
titleOfInvention Preparation of hyaluronidase
abstract The invention comprises a method for the concentration and purification of hyaluronidase starting with an aqueous solution thereof free from tissue and containing an acid buffer system at pH 4.0-5.0 and strong electrolyte to make the ionic strength 0.1-0.25; such a solution is cooled to 0 DEG C., alcohol is added to give a concentration of 30-40 per cent by volume, when some hyaluronidase is precipitated; the solution is then cooled to -5 DEG C. or below and further alcohol is added to give a volume concentration of at least 61 per cent, when more hyaluronidase is precipitated and is separated at - 5 DEG C. or below. If desired, one or more intermediate additions of alcohol are made, e.g. to give a volume concentration of 50-55 per cent. The precipitated hyaluronidase-containing material may be separated after any or all of the additions of alcohol. It may then be dissolved in water and lyophilized to give a dry preparation substantially free from inactive proteinaceous materials. Examples are given of the process using acid sodium acetate as buffer and sodium chloride as electrolyte. Other suitable buffers and electrolytes are mentioned. Specifications 651,544 and 651,545 are referred to.
priorityDate 1950-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA3QVN2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86687
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCR4J7Z9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CH89
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54699
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID406146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI0CME8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB3EWP2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID174383
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ08169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ3S820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15316
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9U6V9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86274
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26831
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCW0HFN9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA3QVN6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI0CME7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HKM3

Total number of triples: 42.